NALCN and non-small cell lung carcinoma: More specifically, the relative expression of NALCN (expressed as 2−ΔΔCt) was significantly higher (p = 0.009) in the tissues of 10 NSCLC patients who were relapse-free (mean = 40.7 ± 23.2) than in the 12 patients who had relapsed during the follow-up period (mean = 6.8 ± 1.8) (Figure 3a).